Trump administration pauses new hospice and home health providers’ enrollment in Medicare
Trump administration pauses new hospice and home health providers’ enrollment in Medicare
Trump administration pauses new hospice and home – On Wednesday, the Centers for Medicare and Medicaid Services (CMS) declared a six-month pause on the enrollment of new hospice and home health care providers under Medicare. This decision marks the latest step in the administration’s campaign to address what officials describe as a surge in fraudulent activities within the healthcare sector. The move aims to restrict access for potentially unscrupulous entities while the agency intensifies its scrutiny of existing programs.
Targeting Fraud with a Moratorium
CMS Administrator Dr. Mehmet Oz emphasized the urgency of the situation, stating in a statement that systemic fraud has infiltrated the hospice and home health care sectors. “We’ve identified patterns of exploitation where malicious actors are targeting some of our most vulnerable patients, siphoning funds intended for their care,” Oz explained. The moratorium, he argued, would act as a deterrent, preventing fresh fraudulent schemes from taking root while CMS works to root out existing ones.
“Today we’re shutting the door on fraud—preventing new bad actors from entering Medicare while we aggressively identify, investigate, and remove those already exploiting them.”
Oz’s initiative is closely tied to Vice President JD Vance’s Anti-Fraud Task Force, which has been a central component of the administration’s strategy to combat healthcare discrepancies. The two officials are scheduled to unveil additional fraud-related measures later in the day, signaling a coordinated effort to tighten oversight. Vance, who will also visit Maine on Thursday, has positioned the state as a focal point for these reforms, citing its role in harboring fraudulent practices.
Maine and the Broader Fight Against Fraud
Maine has become a key battleground in the administration’s anti-fraud campaign. In February, during his State of the Union address, President Donald Trump highlighted the state as a hub for fraudulent activities, drawing attention to its Medicaid-funded autism treatment programs. Recently, CMS directed its scrutiny to Maine, prompting Governor Janet Mills—a Democrat—to respond with criticism, labeling the initiative a “political attack.”
Mills’s remarks reflect a growing tension between the administration’s enforcement actions and the perception of partisan targeting. Meanwhile, the state’s Senate race, where GOP Senator Susan Collins is vying for a sixth term, is expected to be one of the most competitive races in the upcoming November midterms. This context underscores the political stakes of the CMS’s measures, as they may influence voter sentiment in key battlegrounds.
Expanding the Scope of Fraud Investigations
In addition to the recent moratorium, CMS has implemented a range of actions across multiple states. Earlier this year, the agency suspended payments to Minnesota’s Medicaid program, citing concerns over improper spending. Oz has also taken a more proactive approach by engaging directly with state leaders, sending letters and recording videos to demand accountability. These efforts include urging governors to develop strategies for identifying fraudulent actors and ensuring the integrity of their programs.
For example, in February, Oz addressed Maine Governor Janet Mills, emphasizing the need for transparency in the state’s autism care initiatives. The administrator’s focus on durable medical equipment providers has similarly expanded, with CMS imposing a six-month suspension on companies offering items like wheelchairs and oxygen equipment. This nationwide pause follows previous actions targeting specific regions, including Los Angeles, where CMS has suspended $70 million in payments to 773 hospices and 23 home health agencies suspected of misconduct.
Impact on Healthcare Access
While the administration frames the moratorium as a necessary step to curb fraud, critics argue it may inadvertently restrict access to essential services. The National Alliance for Care at Home warned that such pauses could strain care availability, especially in rural and underserved areas. “An enrollment moratorium raises serious access-to-care concerns in regions where patient demand is rising or existing capacity is already stretched,” the group stated. “This leads to longer wait times, reduced service options, and fewer choices for patients.”
Recent actions by CMS have included revoking licenses for hundreds of hospice and home health agencies, as well as enhancing oversight in states like Arizona, California, Georgia, Nevada, and Texas. These efforts have also led to expanded reviews of claims in Florida, Illinois, Oklahoma, and North Carolina. The agency has conducted site visits to assess compliance and has intensified audits to uncover irregularities. However, these measures have sparked debates about their effectiveness and potential unintended consequences.
Political and Economic Motivations
Trump officials have consistently framed fraud as a pervasive issue across the healthcare system. Oz’s focus on hospice care reflects a broader strategy to target specific sectors, with the Los Angeles area serving as a testing ground for these policies. The administration’s emphasis on durable medical equipment providers and Medicaid programs suggests a pattern of addressing high-risk areas where financial mismanagement is suspected.
Oz’s approach has drawn both support and skepticism. While some laud the proactive stance against fraud, others question whether the measures are overly broad. The National Alliance for Care at Home, for instance, has advocated for targeted enforcement that doesn’t disrupt legitimate providers. The group noted that CMS has already received recommendations from various organizations, including strategies to differentiate between fraudulent actors and those operating in good faith.
Long-Term Implications
The six-month pause on new enrollments is part of a larger effort to reshape the Medicare landscape. Officials have stressed the need for stricter vetting processes, increased audits, and quicker removal of problematic entities. However, the long-term impact remains uncertain. If the moratorium is extended or made permanent, it could reshape the competitive landscape for providers, potentially driving up costs or reducing service availability.
As the administration continues its anti-fraud initiatives, the balance between preventing financial abuses and maintaining access to care will be critical. The decision to target specific regions and sectors highlights a strategic focus on areas with high fraud rates, but it also raises questions about the broader implications for healthcare delivery. With the midterms approaching, the political ramifications of these actions may become even more pronounced, as voters weigh the benefits of tighter oversight against the risks of reduced service options.
Overall, the CMS’s moratorium reflects a combination of policy and political objectives. While the immediate goal is to cut down on fraudulent activities, the long-term effects could influence how healthcare services are structured and accessed in the future. As the administration moves forward, its ability to address concerns about patient access will determine the success of its broader agenda.
